362 related articles for article (PubMed ID: 28105937)
21. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
22. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin.
Xu S; Catapang A; Doh HM; Bayley NA; Lee JT; Braas D; Graeber TG; Herschman HR
J Nucl Med; 2018 Jun; 60(2):212-7. PubMed ID: 29880505
[TBL] [Abstract][Full Text] [Related]
23. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
Kang M; Lee SM; Kim W; Lee KH; Kim DY
Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
[TBL] [Abstract][Full Text] [Related]
24. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
25. Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration.
Katagiri M; Karasawa H; Takagi K; Nakayama S; Yabuuchi S; Fujishima F; Naitoh T; Watanabe M; Suzuki T; Unno M; Sasano H
Histol Histopathol; 2017 Apr; 32(4):351-360. PubMed ID: 27363977
[TBL] [Abstract][Full Text] [Related]
26. HK2 Recruitment to Phospho-BAD Prevents Its Degradation, Promoting Warburg Glycolysis by Theileria-Transformed Leukocytes.
Haidar M; Lombès A; Bouillaud F; Kennedy EJ; Langsley G
ACS Infect Dis; 2017 Mar; 3(3):216-224. PubMed ID: 28086019
[TBL] [Abstract][Full Text] [Related]
27. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
Kim JE; Ahn BC; Hwang MH; Jeon YH; Jeong SY; Lee SW; Lee J
J Nucl Med; 2011 Nov; 52(11):1756-63. PubMed ID: 21994409
[TBL] [Abstract][Full Text] [Related]
28. [Knockdown of hexokinase 2 (HK2) inhibits breast cancer cell proliferation and reduces their resistance to fluorouracil].
Wang J; Tao M; Wang T; Wang Z; Xiao J; Ding S; Chen R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Aug; 37(8):722-727. PubMed ID: 34236032
[TBL] [Abstract][Full Text] [Related]
29. [miR-181c inhibits glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts].
Lan H; Luo L; Qi X; Gong Y; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1619-23. PubMed ID: 26607087
[TBL] [Abstract][Full Text] [Related]
30. Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target.
Ferreira JC; Khrbtli AR; Shetler CL; Mansoor S; Ali L; Sensoy O; Rabeh WM
J Biol Chem; 2021; 296():100071. PubMed ID: 33187984
[TBL] [Abstract][Full Text] [Related]
31. High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3.
Cavalcante IP; Zerbini MC; Alencar GA; Mariani Bde P; Buchpiguel CA; Almeida MQ; Mendonca BB; Fragoso MC
Acta Radiol; 2016 Mar; 57(3):370-7. PubMed ID: 25766729
[TBL] [Abstract][Full Text] [Related]
32. BAG3 directly stabilizes Hexokinase 2 mRNA and promotes aerobic glycolysis in pancreatic cancer cells.
An MX; Li S; Yao HB; Li C; Wang JM; Sun J; Li XY; Meng XN; Wang HQ
J Cell Biol; 2017 Dec; 216(12):4091-4105. PubMed ID: 29114069
[TBL] [Abstract][Full Text] [Related]
33. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.
Xu W; Zhang Z; Zou K; Cheng Y; Yang M; Chen H; Wang H; Zhao J; Chen P; He L; Chen X; Geng L; Gong S
Cell Death Dis; 2017 May; 8(5):e2761. PubMed ID: 28471448
[TBL] [Abstract][Full Text] [Related]
34. HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection.
Tan VP; Miyamoto S
Autophagy; 2015; 11(6):963-4. PubMed ID: 26075878
[TBL] [Abstract][Full Text] [Related]
35. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
36. Targeting hexokinase 1 alleviates NLRP3-mediated inflammation in apical periodontitis: A laboratory investigation.
Qian Y; Chen D; Zhu Y; Wu J; Wang Y; Yang W
Int Endod J; 2023 Jun; 56(6):734-747. PubMed ID: 36938709
[TBL] [Abstract][Full Text] [Related]
37. Construction and identification of an RNA interference lentivirus vector targeting the Ras homology C gene of melanoma cells.
Wang Q; Wang X; Zhai X; Zhang J; Chen M; Liu L
Chin Med J (Engl); 2014; 127(7):1339-43. PubMed ID: 24709191
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.
Song J; Wu X; Liu F; Li M; Sun Y; Wang Y; Wang C; Zhu K; Jia X; Wang B; Ma X
Biochem Biophys Res Commun; 2017 Aug; 490(2):217-224. PubMed ID: 28602700
[TBL] [Abstract][Full Text] [Related]
39. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
40. Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1.
Magalhães RSS; Boechat FC; Brasil AA; Neto JRM; Ribeiro GD; Paranhos LH; Neves de Souza N; Vieira T; Outeiro TF; Neves BC; Eleutherio ECA
J Cell Biochem; 2022 Nov; 123(11):1808-1816. PubMed ID: 35944097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
